June 19, 2017
IGENOMIX receives EMA Orphan Drug Designation for its product indicated for Asherman’s Syndrome with Asphalion support
We are proud to announce that our product autologous adult bone marrow-derived non-expanded CD133+ haematopoietic [...]
Read More
